Serum amyloid A as a marker of disease activity in Giant cell arteritis
Anaïs Dartevel(Centre Hospitalier Universitaire de Grenoble), Laurence Bouillet(University of California, Irvine), M Arnaud(Centre Hospitalier Universitaire de Grenoble), Candice Trocmé(Centre Hospitalier Universitaire de Grenoble), Nicolas Simon(Université de Lille), Patrice Faure(Inserm), Bertrand Toussaint(Centre National de la Recherche Scientifique)
Cited by 14
Related Papers
The global impact of the COVID‐19 pandemic on the management and course of chronic urticaria
|Allergy|2020|89
International Consensus on the Use of Genetics in the Management of Hereditary Angioedema
|The Journal of Allergy and Clinical Immunology In Practice|2019|80
Clinical and pathological features of cutaneous manifestations in VEXAS syndrome: A multicenter retrospective study of 59 cases
|Journal of the American Academy of Dermatology|2022|67
Pneumocystis jirovecii pneumonia in intensive care units: a multicenter study by ESGCIP and EFISG
|Critical Care|2023|65
Levamisole-induced vasculopathy: A systematic review
|Seminars in Arthritis and Rheumatism|2018|61